Molecular Metabolism
2018
“LY3298176, a novel dual GIP and GLP-1 receptor agonist for the treatment of type 2 diabetes mellitus: From discovery to clinical proof of concept”
Coskun T, et al.
PubMed →vitalitiRX
loading product
Weight Loss
Tirzepatide
The dual-agonist with clinical track record.
Appetite · Blood sugar · Weight loss
The proven weight-loss compound with real-world data
dual-agonist
vitalitiRX
loading vial
Size
Discreet packaging · 3–5 day Canadian shipping · COA available for your exact lot
Sold for laboratory and research purposes only. Not for human consumption. Not evaluated by Health Canada.
mechanism
How it works.
Tirzepatide is a dual-agonist* that binds both the GLP-1 and GIP receptors. It has the clearest clinical track record in the GLP-1 category, with phase 3 data across weight management and type 2 diabetes indications.
- ↳GLP-1 + GIP only
The dual-receptor mechanism is associated with appetite suppression via GLP-1 pathways and insulin sensitivity* improvements associated with GIP signaling. Clinical trials have reported weight reduction and metabolic improvement across multiple dose tiers.
- ↳GIP arm — see SURPASS
Protocols are typically titrated over 12–16 weeks to allow GI adaptation*, which is the limiting factor in real-world dosing.
- ↳nausea peaks wk 2–4
GLP-1 + GIP only
GIP arm — see SURPASS
nausea peaks wk 2–4
research references
Selected literature.
3 citations
protocol
Handling & dosing.
- Dosing frequency
- Weekly subcutaneous injection, titrated over 12–16 weeks
- Reconstitution
- Reconstitute with 2–3 mL bacteriostatic water per 10 mg vial
- Storage
- 2–8°C, avoid light. Reconstituted vials stable for up to 30 days refrigerated.
verification · per-lot
The COA, in shape.
Every lot ships with an independent Certificate of Analysis on file. Below is the format your lot's COA arrives in — HPLC chromatogram, identity, endotoxin, the works. Request the document for the exact lot you receive.
request your lot's coa →vitalitiRX
Certificate of Analysis
LOT
BC-0429-01
COMPOUND
Tirzepatide 5MG
MFG
04 / 2026
EXP
05 / 2027
PURITY98.4%
IDENTITYMASS-MATCHED
ENDOTOXINBELOW LOQ
RESIDUAL SOLVENTSPASSED
Tested by
R. Okonkwo
QC Manager
Date
14 April 2026
Illustrative · actual per-lot COA available on request.
researcher reviews
From verified buyers.
4.8
★★★★★
based on 15 verified reviews
“Cold-chain packaging was thorough, vials arrived properly stored. Lot code on the label matched the COA on the verification page exactly. Documentation is what vitalitiRX does better than competitors.”
Angela F · Surrey✓ verified
“Ordered the 20mg size. Vial integrity was intact, seal was tamper-evident. Reconstitution instructions were clear. The structured titration guidance in the protocol notes is genuinely useful for someone new to this category.”
Jamie O · Quebec City✓ verified
“Quick shipping, secure packaging. The COA was the deciding factor over Alibaba sourcing — being able to verify the lot before opening the vial is the bare minimum I expect now and most suppliers don’t offer it.”
Tariq N · Toronto✓ verified
reviews describe product + service only — purity, packaging, lot traceability, fulfilment, COA access. per health canada guidance, claims about diagnosis, treatment, or specific outcomes are edited out before publication.
Research use only. Not for human consumption. Not approved by Health Canada for therapeutic use.
